Clopidogrel, Prasugrel or Ticagrelor in Patients with Acute Coronary Syndromes undergoing Percutaneous Coronary Intervention.

Clopidogrel, Prasugrel or Ticagrelor in Patients with Acute Coronary Syndromes undergoing Percutaneous Coronary Intervention.

Background: Guidelines recommend prasugrel or ticagrelor instead of clopidogrel in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary interventions (PCI). Aim: We sought to describe the trends in uptake of the newer agents and analyse the clinical characteristics and short...

Full description

Bibliographic Details
Main Authors: Yudi, M., Clark, D., Farouque, O., Eccleston, D., Andrianopoulos, N., Duffy, S., Brennan, A., Lefkovits, J., Ramchand, J., Yip, T., Oqueli, E., Reid, Christopher, Ajani, A., Melbourne Interventional Group
Format: Journal Article
Published: 2016
Online Access:http://hdl.handle.net/20.500.11937/28555

Internet

http://hdl.handle.net/20.500.11937/28555

Similar Items